Thermo Fisher raises over half of Patheon consideration in four tranches
Thermo Fisher Scientific announced in May that it was to acquire Patheon for $7.2bn, including $2bn of net debt. Thermo Fisher expected to finance the deal with $5.2bn of debt and $2bn of equity. On Tuesday it put a big dent in the debt figure with a €2.6bn four tranche corporate bond offer.
According to Bloomberg data, Thermo Fisher has paid $29.2bn for various acquisitions in the past five years. In this period, the shares of Thermo Fisher have tripled to over $180 at Monday’s close.Monday’s announcement about the call said Thermo Fisher was planning a multi-tranche euro transaction including ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org